Indi(R) Secures $6.1 Million in Financing and Major Medicare Coverage Milestone for Xpresys(R) Lung Molecular Diagnostic For Ruling Out Lung Cancer
January 06, 2017 08:00 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - January 06, 2017) - Indi (Integrated Diagnostics®) today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) and national Medicare MolDx program...
Widespread Overtreatment of Benign Lung Nodules Seen in Landmark Chart Review Study
June 22, 2015 12:24 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Jun 22, 2015) - Indi (Integrated Diagnostics®) today announced CHEST has published a landmark chart review study, suggesting widespread overtreatment of benign lung...
Indi(R) Publishes Technical Paper on Methods to Improve Reproducibility and Robustness of MRM-Mass Spec Proteomic Tests
March 17, 2015 17:00 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Mar 17, 2015) - Indi (Integrated Diagnostics®) today announced publication of a technical paper in Clinical Proteomics providing details about the assay variability...
Indi(R) Announces Agreement to License Xpresys(R) Lung in Canada to Caprion
February 03, 2015 09:30 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Feb 3, 2015) - Indi (Integrated Diagnostics®) today announced an exclusive agreement to license Xpresys Lung in Canada to Caprion. Xpresys Lung is Indi's...
Landmark Indi(R) Publication Shows Xpresys(R) Lung Helps Identify Benign Lung Nodules
January 29, 2015 07:30 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Jan 29, 2015) - Indi (Integrated Diagnostics®) today announced that the Journal of Thoracic Oncology (JTO) has published positive results from a landmark clinical...
Indi(R) Appoints Douglas Sanders CFO
January 08, 2015 07:30 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Jan 8, 2015) - Indi (Integrated Diagnostics®), a molecular diagnostics company pioneering the use of blood-based proteomic tests, today announced that it has...
Indi Molecular(R) and Sigma-Aldrich(R) Establish Collaboration to Explore Use of PCC Technology in Biological Tools
December 17, 2014 07:30 ET
|
Indi Molecular
CULVER CITY, CA--(Marketwired - Dec 17, 2014) - Indi Molecular, the maker of a synthetic replacement for monoclonal antibodies, today announced that it has entered into a co-development agreement...
Indi(R) Secures Contracts for Xpresys(R) Lung With Multiplan and Five Other PPOs; Blood Test for Pulmonary Nodules Now Available to 200 Million Covered Lives
November 05, 2014 08:30 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Nov 5, 2014) - Indi® (Integrated Diagnostics), an emerging leader in molecular diagnostics, today announced that the company has secured contractual agreements with...
Indi(R) Announces $47.25 Million in Funding for Blockbuster Diagnostic
April 29, 2014 07:30 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Apr 29, 2014) - Indi® (Integrated Diagnostics), a molecular diagnostics company pioneering the use of blood-based proteomic tests, announced today it has raised...
Indi Molecular Expands Seed Round to $1.8 Million With Additional $300K From Asset Management Ventures
December 10, 2013 07:01 ET
|
Integrated Diagnostics
CULVER CITY, CA--(Marketwired - Dec 10, 2013) - Indi Molecular, which pioneered a synthetic replacement for antibodies, today announced that it has raised an additional $300,000 from a new investor,...